MedPath

PHYSOSTIGMINE SALICYLATE

PHYSOSTIGMINE SALICYLATE INJECTION (1mg/mL) 2mL AMPULE

Approved
Approval ID

9a448a78-356c-50f7-e053-2995a90adefa

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2023

Manufacturers
FDA

HF Acquisition Co LLC, DBA HealthFirst

DUNS: 045657305

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PHYSOSTIGMINE SALICYLATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51662-1439
Product Classification
G
Generic Name
PHYSOSTIGMINE SALICYLATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 9, 2023
FDA Product Classification

INGREDIENTS (4)

SODIUM METABISULFITEInactive
Code: 4VON5FNS3C
Classification: IACT
BENZYL ALCOHOLInactive
Code: LKG8494WBH
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
PHYSOSTIGMINE SALICYLATEActive
Quantity: 1 mg in 1 mL
Code: 2046ZRO9VU
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

PHYSOSTIGMINE SALICYLATE - FDA Drug Approval Details